HWKN

Hawkins, Inc. (HWKN) - Q3 2026 Filing Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended December 28, 2025 (Fiscal Q3 2026). Hawkins, Inc. is a distributor of water treatment solutions, specialty ingredients, and chemicals. Effective with this quarter, the company realigned its reporting segments to Water Treatment, Food & Health Sciences, and Industrial Solutions to reflect its evolution from a bulk commodity distributor to a specialty ingredients company. Historical data has been recast to align with these new segments.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Sales increased 8% quarter-over-quarter and 12% year-over-year (YTD). Growth was driven by the Water Treatment segment (+21% Q/Q, +23% YTD) and Industrial Solutions segment (+10% Q/Q, +7% YTD). The Food & Health Sciences segment declined 10% Q/Q due to lower volumes in food, nutrition, and agricultural products.
• Acquisition Impact: The company completed the acquisition of WaterSurplus, Inc. for approximately $150 million in April 2025. This deal contributed roughly $19 million in sales for the quarter and $70 million YTD. Total acquisition spending for the nine months was $167.1 million.
• Margin Compression: Gross margin decreased slightly to 20.8% (from 21.4% prior year) due to a higher mix of lower-margin bulk commodity products and increased intangible amortization from acquisitions. Operating margin declined to 9.2% from 9.3%.
• Increased Interest Expense: Net interest expense rose to $3.4 million (from $1.2 million) due to increased borrowings to fund the WaterSurplus acquisition. The effective interest rate on borrowings was 4.8%.
• SG&A Expenses: SG&A increased 3% Q/Q, driven by $5.4 million in costs from acquired businesses, partially offset by a $4.6 million favorable fair value adjustment to a prior earnout liability.

Guidance, Outlook, and Risks

• Outlook: Management expects the full-year effective tax rate to be approximately 26% to 27%. No specific revenue or earnings guidance was provided in this text.
• Liquidity: The company maintains a $400 million revolving credit facility (matured April 2030). As of period end, $264 million was drawn. Management believes cash balances and credit facility availability are sufficient for ongoing operations.
• Share Repurchases: No shares were repurchased in the current quarter or YTD. Approximately 731,544 shares remain available under the existing program.
• Risks & Contingencies:
  • Environmental: A $7.7 million liability is recorded for PCB remediation at the Rosemount, MN facility. No expenses were charged against this reserve in the current period.
  • Earnout Liabilities: Total earnout liabilities increased to $50.8 million, primarily due to the WaterSurplus acquisition ($44.4 million).
  • Commodity Prices: The company is exposed to cyclical chemical prices and relies on passing cost increases to customers.

Investor Verification Checklist

• Acquisition Integration: Verify the timeline for WaterSurplus to reach profitability, as it reported an operating loss of $1.6 million for the quarter.
• Debt Covenants: Confirm compliance with the Credit Agreement's leverage ratios (max 3.5x, extendable to 4.0x) given the significant increase in debt load.
• Food & Health Sciences Decline: Investigate the sustainability of the 10% sales decline in this segment and the impact of competitive pricing pressures.
• Environmental Reserve: Monitor the $7.7 million PCB remediation reserve for potential increases in estimated costs.
• Earnout Volatility: Track the fair value adjustments of the $50.8 million in earnout liabilities, which impact SG&A and net income.